Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.

8 references·16 citing·24 second hop

FromToDepth

this work references cited by second hop

References

2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
2000Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases218 cited
2000NAT of the United States and Canadian blood supply142 cited
2001Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India.131 cited
2003High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan101 cited
2006Hepatitis B virus blood screening: unfinished agendas94 cited

Cited by

2021Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions66 cited
2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
2012Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections48 cited
2010Nucleic acid testing (NAT) in high prevalence–low resource settings47 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2012Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 200936 cited

2015Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety35 cited

2017Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia30 cited

2015Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan29 cited

2014Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India25 cited

2014Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan19 cited

2023Time Trend and Prevalence Analysis of Transfusion Transmitted Infections among Blood Donors: A Retrospective Study from 2001 to 201619 cited

2013Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors18 cited

2014Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus17 cited

2014A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India17 cited

2014Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity16 cited

2010Frequency of HIV type 2 infections among blood donor population from India: A 10-year experience16 cited